ACTIVE

AEXIS INTERNATIONAL

Financial year 2025 · Closed on 31/12/2025

Net result114,7 k €-41,4 %over 1 year
Revenue10 M €+10,1 %over 1 year
Equity6,4 M €+1,8 %over 1 year
Workforce1,8 ETP0,0 %over 1 year

Identity

Source · BCE/KBO

AEXIS INTERNATIONAL is a Public limited company incorporated in 1998. Its main activity is: Wholesale of information and communication equipment. Its registered office is in Zaventem. It employs on average 1,8 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0464.642.569
Incorporation
23/11/1998
Legal form
Public limited company
Registered office
Leuvensesteenweg 392b
1932 Zaventem · FlandreSee on map
Contributed capital
403 863,94 €
Latest accounts
31/12/2025
Average workforce
1,8 ETP
Joint committees (2)
  • 200
  • 218
Signals
ProfitableSolid equityPositive cashflowPositive EBITDAHealthy social debtsHigh revenue

Financials

Source · NBB, 20 filings

Trend over 20 financial years

20252024202320222021
Income statement
Revenue10 M €9,1 M €9,8 M €8,6 M €8,6 M €
EBITDA178,5 k €287,8 k €669,6 k €100,9 k €263,5 k €
Operating result172 k €285,3 k €635,7 k €94,9 k €247,3 k €
Net result114,7 k €195,7 k €2,9 M €36,1 k €1,4 M €
Balance sheet
Equity6,4 M €6,3 M €6,1 M €3,2 M €4,1 M €
Total assets18,4 M €18 M €19 M €14,4 M €16 M €
Cash2,7 M €2,3 M €267,1 k €525,6 k €609,1 k €
Debts12 M €11,3 M €12 M €11 M €11,4 M €
Other
Workforce1,8 ETP1,8 ETP1,8 ETP1,8 ETP1,8 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

3 active · 25 ended

Active mandates

AEXIS GROUP

Director · since 01 juillet 2020 · until 26 juin 2026 · 0644.747.419

Represented by Redouane Bennani

Active
JOKACE

Managing director · since 01 juillet 2020 · until 26 juin 2026 · 0748.917.204

Represented by Serge Pensaert

Active
Medtech Group

Director · since 01 juillet 2020 · until 26 juin 2026 · 0716.909.380

Represented by Said Rkaibi

Active

Ended mandates

AEXIS GROUP

Director · since 01 juillet 2020 · until 30 juin 2026 · 0644.747.419

Represented by Redouane Bennani

Ended
JOKACE

Managing director · since 01 juillet 2020 · until 30 juin 2026 · 0748.917.204

Represented by Serge Pensaert

Ended
Medtech Group

Director · since 01 juillet 2020 · until 30 juin 2026 · 0716.909.380

Represented by Said Rkaibi

Ended
Frank PEETERS

Managing director · since 21 mai 2004 · until 21 mai 2010

Ended

Other companies at this address

Leuvensesteenweg 392b 1932 Zaventem
CompanyCBE no.
Aexis Unité● Active
0731.800.563

Full financial information

Source · NBB
202520242023202220212020
Type of accountFull modelFull modelFull modelFull modelFull modelFull model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date03/07/202601/07/202503/07/202405/07/202318/07/202226/07/2021
General meeting26/06/202627/06/202528/06/202430/06/202330/06/202230/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 20 filings
ModelClosingGeneral meetingFiledLanguageDocument
Full model31/12/202526/06/202603/07/2026DutchPDF
Full model31/12/202427/06/202501/07/2025DutchPDF
Full model31/12/202328/06/202403/07/2024DutchPDF
Full model31/12/202230/06/202305/07/2023DutchPDF
Full model31/12/202130/06/202218/07/2022DutchPDF
Full model31/12/202030/06/202126/07/2021DutchPDF
Full model31/12/201915/05/202012/06/2020DutchPDF
Full model31/12/201828/06/201921/08/2019DutchPDF
Full model31/12/201729/06/201830/08/2018DutchPDF
Full model31/12/201630/06/201704/07/2017DutchPDF
Full model31/12/201530/06/201626/08/2016DutchPDF
Full model31/12/201422/06/201529/06/2015DutchPDF
Full model31/12/201330/06/201408/07/2014DutchPDF
Full model31/12/201228/06/201327/08/2013DutchPDF
Full model31/12/201128/06/201231/07/2012DutchPDF
Full model31/12/201029/06/201111/08/2011DutchPDF
Full model31/12/200929/06/201027/08/2010DutchPDF
Full model31/12/200823/06/200929/07/2009DutchPDF
Full model31/12/200730/06/200826/08/2008DutchPDF
Full model31/12/200607/06/200714/06/2007DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

3 active · 25 ended

Active mandates

AEXIS GROUP

Director · since 01 juillet 2020 · until 26 juin 2026 · 0644.747.419

Represented by Redouane Bennani

Active
JOKACE

Managing director · since 01 juillet 2020 · until 26 juin 2026 · 0748.917.204

Represented by Serge Pensaert

Active
Medtech Group

Director · since 01 juillet 2020 · until 26 juin 2026 · 0716.909.380

Represented by Said Rkaibi

Active

Ended mandates

AEXIS GROUP

Director · since 01 juillet 2020 · until 30 juin 2026 · 0644.747.419

Represented by Redouane Bennani

Ended
JOKACE

Managing director · since 01 juillet 2020 · until 30 juin 2026 · 0748.917.204

Represented by Serge Pensaert

Ended
Medtech Group

Director · since 01 juillet 2020 · until 30 juin 2026 · 0716.909.380

Represented by Said Rkaibi

Ended
Frank PEETERS

Managing director · since 21 mai 2004 · until 21 mai 2010

Ended

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Capital / shares28/11/2025
    KAPITAAL - AANDELEN
    PDF
  • Other10/03/2025
    DIVERSEN
    PDF
  • Mandates10/03/2025
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Capital / shares03/05/2024
    KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …)
    PDF
  • Mandates16/01/2023
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates05/05/2021
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates31/08/2020
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates28/12/2018
    ONTSLAGEN - BENOEMINGEN
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025114,7 k €↓
  2. 2024
    Annual accounts 2024195,7 k €↓
  3. 2023
    Annual accounts 20232,9 M €↑
  4. 2022
    Annual accounts 202236,1 k €↓
  5. 2021
    Annual accounts 20211,4 M €↑
  6. 2020
    Annual accounts 2020364,7 k €↓
  7. 2019
    Annual accounts 2019758,3 k €↓
  8. 2018
    Annual accounts 2018761,9 k €↓
  9. 2017
    Annual accounts 20171,4 M €↑
  10. 2016
    Annual accounts 2016942,3 k €↑
  11. 2015
    Annual accounts 2015513,3 k €↑
  12. 2014
    Annual accounts 2014-1,3 M €↓
  13. 2013
    Annual accounts 2013-832,8 k €↓
  14. 2012
    Annual accounts 201223,3 k €↓
  15. 2011
    Annual accounts 20111,5 M €↑
  16. 2010
    Annual accounts 2010218,8 k €↓
  17. 2009
    Annual accounts 2009413,9 k €↑
  18. 2008
    Annual accounts 2008263,5 k €↓
  19. 2007
    Annual accounts 20072,3 M €↑
  20. 2006
    Annual accounts 20062,1 M €
  21. 23/11/1998
    IncorporationPublic limited company